January 30, 2019
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Read More
January 30, 2019
Long-term Extension From RCC Phase II (11515)
Read More
January 30, 2019
Long-term Extension From RCC Phase II (11515)
Read More
January 30, 2019
Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)
Read More
January 30, 2019
Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)
Read More
January 30, 2019
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Read More
January 30, 2019
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Read More
January 30, 2019
Study of SU011248 in Patients With Advanced Kidney Cancer
Read More
January 30, 2019
Study of SU011248 in Patients With Advanced Kidney Cancer
Read More
January 30, 2019
Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
Read More
January 30, 2019
Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
BAY43-9006 Phase II Study for Renal Cell Carcinoma
Read More
Load More
X